The Pre-Op Question Patients Lie About: Cannabis and the Anesthesia Dose Nobody Can Guess

There is a moment in the pre-operative interview that goes wrong more often than any other, and it is not a complicated one. The anesthesiologist asks about recreational drug use. The patient, who takes a ten milligram gummy four nights a week and buys it at a licensed dispensary two blocks from the surgery center, says no.

They are not lying, exactly. They are answering the question that was asked. "Drug use" reads as heroin and cocaine, as something furtive and illegal, and the thing in their nightstand drawer is taxed, tested, labeled, and sold next to a coffee shop. The category the form is reaching for and the category the patient lives in stopped overlapping years ago.

The consequence lands in the operating room. Regular cannabis users can require noticeably more sedative to reach the same depth of anesthesia, they arrive with a more reactive airway if they smoke it, and they report more pain and consume more opioid after surgery than comparable patients who do not use. None of that is dangerous when the anesthesiologist knows. All of it is a problem when they are finding out by watching the patient fail to go under.

The disclosure gap is a wording problem, not a compliance problem

The short answer: patients withhold cannabis use at high rates, and the primary driver is that intake forms ask about illicit drugs while patients now file cannabis with alcohol and supplements.

Perioperative teams have been describing this gap for years, and the survey work behind it is consistent: a meaningful share of cannabis users do not report it to their surgical team, and among those who do not, the most common stated reason is that they were never asked in a way that seemed to apply to them. Some also expect judgment, or worry that disclosure will get the case canceled.

The legal landscape did most of this work. Recreational use is now permitted for adults in roughly half the states and medical use in most of them, and the product itself has changed alongside the law. Federal monitoring of seized cannabis showed average THC concentration in flower rising from the low single digits in the early 1990s to well above fifteen percent in recent years, and concentrates sold openly in dispensaries run far higher than that. A patient who used occasionally in college and uses occasionally now is not having the same pharmacological experience in those two decades.

So the honest framing is not that patients are hiding something. It is that the question is obsolete. The practices that get accurate answers have stopped asking about drugs and started asking a plain one: do you use cannabis in any form, including edibles, vapes, or tinctures, and how often.

What it actually does to sedation

The short answer: chronic cannabis use is associated with higher anesthetic requirements, most clearly documented with propofol, and the effect is large enough that an unaware anesthesiologist will be dosing behind the patient rather than ahead of them.

The most cited evidence here is a retrospective study of endoscopy patients in Colorado, published in 2019, which compared sedation requirements between self-reported cannabis users and non-users. Cannabis users needed substantially more of all three agents used, with the largest difference in propofol by a wide margin. It is a small single-center study of a few hundred patients, it relies on self-report, and it should not be read as a precise dosing multiplier. What it does establish, alongside the case reports and the broader tolerance literature, is direction and rough magnitude, and both have been reproduced often enough that anesthesiologists now treat it as a working assumption rather than a curiosity.

The mechanism is unsurprising. Cannabinoid receptors are distributed throughout the central nervous system, chronic exposure produces receptor downregulation and functional tolerance, and cross-tolerance with other sedative agents follows the same pattern seen with alcohol. Someone who is pharmacologically accustomed to being sedated every evening is harder to sedate on a Tuesday morning.

The practical effect is not that the operation becomes unsafe. It is that the anesthesiologist either titrates up quickly during induction, which is manageable, or is surprised during a procedure where being surprised is expensive. Intraoperative awareness under sedation, an agitated emergence, or a patient moving during a delicate maneuver are all downstream of the same missing sentence at intake.

"

The intake form asks about drug use. The patient files cannabis with wine and melatonin. Both parties then act in good faith on completely different information, and the operating room absorbs the difference.

"

Airway, heart, and the two hours after you smoke

The short answer: smoked or vaporized cannabis irritates the airway and raises heart rate acutely, and the first consensus guideline in this area recommends delaying elective surgery in a patient who has recently inhaled.

In 2023 the American Society of Regional Anesthesia and Pain Medicine published the first formal consensus guidelines on perioperative cannabis use, and the American Society of Anesthesiologists issued patient-facing guidance at the same time. Three recommendations matter to anyone scheduling an elective cosmetic procedure.

• Universal screening. Every patient should be asked about cannabis use, including route and frequency, rather than asked about drugs generally.
• Delay for acute intoxication. Elective surgery should be postponed in a patient who is currently intoxicated, and the guideline specifically flags the window shortly after inhalation because of the transient cardiovascular effect.
• Counseling on pain. Patients should be told before surgery that regular use is associated with more postoperative pain and higher opioid requirements, so that the recovery plan is built accordingly.

The cardiovascular caution has a specific evidentiary root. Work published in Circulation in 2001 found a sharply elevated risk of myocardial infarction in the hour immediately following cannabis use, an acute effect driven by heart rate and sympathetic tone. In a healthy thirty-year-old having liposuction this is close to theoretical. In an older patient with any cardiac history, layered onto the stress of an operation, it is a reason to move the case rather than proceed.

The airway concern is more routine and more relevant to the day itself. Inhaled cannabis, whether combusted or vaporized, produces airway irritation and hyperreactivity, and reactive airways are the setting in which laryngospasm and coughing during airway manipulation become likelier. This is a different problem from the wound-healing question that drives the pre-op smoking cessation timelines surgeons enforce for nicotine, and the nicotine evidence does not transfer cleanly. Cannabis has not been studied for wound healing anywhere near as thoroughly, and any surgeon who tells you the four-week nicotine rule has been validated for cannabis is extrapolating.

Pain afterward, nausea, and the CBD interaction nobody screens for

The short answer: regular cannabis users tend to report higher postoperative pain scores and consume more opioid, which is the opposite of what most patients assume, and CBD products carry a real drug interaction through the liver.

The expectation patients bring is intuitive and wrong. Cannabis is a pain product in their experience, so they assume a tolerance for pain rather than a heightened sensitivity to it. Multiple perioperative cohorts have found the reverse: cannabis users report more pain after surgery and require more analgesia, a pattern consistent with cannabinoid tolerance and, in heavier users, with a hyperalgesic state. This matters more now than it did a decade ago, because the field has moved toward multimodal, opioid-sparing recovery protocols that are calibrated to a typical patient. A protocol built on the assumption of modest opioid need will underperform in a heavy user, and the patient experiences that as a practice that does not manage pain well.

Nausea deserves its own line. Cannabis is widely used as an antiemetic, which leads patients to assume protection against postoperative nausea and vomiting. Heavy chronic use runs the other way in a subset of users, producing cyclical vomiting that can be difficult to distinguish from an anesthetic reaction in the recovery room. Knowing the history in advance turns a diagnostic puzzle into a known quantity.

Then there is the interaction that almost nobody screens for. Cannabidiol inhibits several cytochrome P450 enzymes, including CYP3A4 and CYP2C19, which are the same enzymes responsible for clearing a long list of perioperative and everyday medications. High dose CBD, which is now sold as an unregulated wellness product in doses that would have been a clinical trial protocol ten years ago, can meaningfully alter the levels of other drugs. It belongs on the same disclosure list as the supplements you are told to stop before surgery, and it is almost never on the printed one.

What to actually do before an elective case

The short answer: disclose in writing, ask for a stop window rather than guessing at one, and understand that the honest reason to abstain is anesthetic predictability rather than moral hygiene.

There is no single validated abstinence interval, and any clinic quoting one with confidence is quoting a policy rather than a finding. Practices commonly ask for anywhere from twenty-four hours to several weeks, and the range reflects genuine uncertainty. What the evidence supports is narrower and more useful:

• Do not use on the day of surgery. This is the one point with consensus behind it, and it covers both the cardiovascular window and the intoxication question that affects your capacity to consent.
• Tell them the route. Smoked, vaporized, edible, and topical products behave differently. Edibles have a slower onset and longer tail, which matters for a morning case after a Tuesday night gummy.
• Tell them the dose and frequency. Daily heavy use and monthly social use are different clinical situations, and the anesthesiologist is adjusting for tolerance, not judging a lifestyle.
• Expect the anesthetic plan to change, not the surgery. Disclosure usually produces a different induction dose and a different pain plan. Cancellation is reserved for acute intoxication.
• Ask who is delivering the anesthetic. The value of this disclosure depends entirely on it reaching the person titrating the drug, which is one more reason that who administers your anesthesia is a question worth asking out loud rather than assuming.

There is also a withdrawal consideration that cuts against very long abstinence windows imposed without discussion. Heavy daily users asked to stop abruptly for several weeks can experience irritability, insomnia, appetite change, and anxiety, all of which land during the exact period when sleep and calm are doing real work for recovery. That trade belongs in a conversation rather than in a form letter.

The honest summary

Cannabis is now an ordinary consumer product used by an ordinary share of the people booking elective cosmetic surgery, and the perioperative system has not fully caught up to that. The screening question is written in the vocabulary of prohibition, so it collects bad data, and the bad data shows up as a patient who does not go under on schedule and does not get comfortable afterward.

What the evidence supports is modest and specific. Chronic use raises sedative requirements, most clearly for propofol. Inhaled use irritates the airway and produces a short cardiovascular window in which elective surgery should not begin. Regular users hurt more after surgery, not less, and need a pain plan built for that. High dose CBD interacts with the liver enzymes that clear other drugs. None of these findings argue that cannabis users should not have surgery. They argue that the anesthesiologist should know.

The version of this that goes badly is not the patient who uses cannabis. It is the patient who uses cannabis and answers no, then spends the recovery period assuming that a difficult wake-up and an unmanaged first two days were just how surgery goes. They were not. They were the predictable output of one missing sentence, asked poorly and answered honestly.

Say it before they ask. If the practice does not know what to do with the answer, you have learned something worth more than the disclosure cost you.